Manufacturing excellence — with pharma DNA.
Four GMP sites — pharma-trained operations. 700 KL aggregate fermentation capacity. Audited by USFDA, EU-GMP, PMDA, and KFDA.
Pharma-trained operations
Aggregate fermentation capacity
Regulated pharma heritage
Filed across products
Full DSP capability.
End-to-end recovery and purification — from harvest clarification through to pharmacopoeial crystallization.
Microfiltration
Selective particle separation for harvest clarification.
UF / DF
Ultrafiltration and diafiltration — concentration and buffer exchange via tangential-flow membranes.
Centrifugation
High-speed solid-liquid separation across batch scales.
Spray Drying
Liquid concentrate to free-flowing pharmacopoeial-grade powder.
Extraction
Solvent and aqueous isolation routes — solvent-restricted by default.
Crystallization
Final purification step delivering Ph. Eur. crystalline grades.
From microbes to omega-3 algae.
Platforms across bacteria, yeast, fungi, and algae — scaled with pharma-grade controls and documentation.
Bacteria
Industrial fermentation workhorse — recombinant and native strains.
Yeast
Eukaryotic precision — hosts including Vitamin D2 from ergosterol.
Fungi
Filamentous growth for secondary metabolites and biotransformations.
Algae
Photosynthetic platform — Schizochytrium sp. for omega-3 DHA.
Need a pharma-grade manufacturing partner?
Tell us your target market, format, and volumes. Our team replies within 1 business day.